155600-90-1 Usage
Uses
Used in Organic Synthesis:
2,7-Diazaspiro[3.5]nonan-1-one, 2-(phenylmethyl)is utilized as a key intermediate in organic synthesis for the construction of complex organic molecules. Its unique spiro structure and functional groups enable it to serve as a versatile building block, facilitating the synthesis of a wide range of bioactive compounds with potential applications in various fields.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2,7-Diazaspiro[3.5]nonan-1-one, 2-(phenylmethyl)is employed as a potential drug candidate. Its distinctive structure and properties make it a promising starting point for the development of new therapeutic agents. Researchers can explore its potential as a lead compound for the treatment of various diseases by investigating its pharmacological properties, such as its binding affinity, selectivity, and efficacy in biological assays.
Used in Drug Design and Development:
2,7-Diazaspiro[3.5]nonan-1-one, 2-(phenylmethyl)can be used as a structural template in drug design and development. Its unique spiro framework and functional groups provide opportunities for medicinal chemists to modify and optimize its properties, leading to the discovery of new drugs with improved pharmacokinetics, pharmacodynamics, and safety profiles. 2,7-Diazaspiro[3.5]nonan-1-one, 2-(phenylmethyl)can be a valuable asset in the quest for innovative therapeutic agents to address unmet medical needs.
Check Digit Verification of cas no
The CAS Registry Mumber 155600-90-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,6,0 and 0 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 155600-90:
(8*1)+(7*5)+(6*5)+(5*6)+(4*0)+(3*0)+(2*9)+(1*0)=121
121 % 10 = 1
So 155600-90-1 is a valid CAS Registry Number.
155600-90-1Relevant articles and documents
Synthesis of a new series of 2,7-diazaspirononan-1-ones and study of their cholinergic properties
Cignarella, G.,Villa, S.,Barlocco, D.
, p. 115 - 120 (2007/10/02)
A new series of substituted 2,7-diazaspirononan-1-ones (1a-l), structurally related to the muscarinic agonist RS-86, has been synthesized and tested for cholinergic properties both in vitro and in vivo.None of the compounds showed significant cholinergic properties at either the central or peripheral level.A possible explanation for the lack of activity is given.Alzheimer's disease / cholinergic system / RS-86 / muscarinic agonists